A carregar...
EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: What’s New?
In the past 10 to 15 years, a considerable progress has been made in the treatment of gastrointestinal (GI) related malignancies, as a number of agents expanded from only one in 1995 to seven in 2006. Current review describes the recent role of targeted therapies, specifically EGFR inhibitors in the...
Na minha lista:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2010
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3915939/ https://ncbi.nlm.nih.gov/pubmed/20298154 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|